Predictive validity of haloperidol‐based models has extensively been proven thanks to the successful recovery of motor impairment with already established PD treatments, such as L‐DOPA and monoamine oxidase B (MAO‐B) inhibitors (Duty & Jenner, 2011). This evidence concerns the gene MAOB and Parkinson disease.